BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23582061)

  • 1. Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.
    Chen G; Shannon M
    Crit Rev Immunol; 2013; 33(2):165-82. PubMed ID: 23582061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional coactivator TAZ regulates reciprocal differentiation of T
    Geng J; Yu S; Zhao H; Sun X; Li X; Wang P; Xiong X; Hong L; Xie C; Gao J; Shi Y; Peng J; Johnson RL; Xiao N; Lu L; Han J; Zhou D; Chen L
    Nat Immunol; 2017 Jul; 18(7):800-812. PubMed ID: 28504697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
    Ulges A; Witsch EJ; Pramanik G; Klein M; Birkner K; Bühler U; Wasser B; Luessi F; Stergiou N; Dietzen S; Brühl TJ; Bohn T; Bündgen G; Kunz H; Waisman A; Schild H; Schmitt E; Zipp F; Bopp T
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10145-50. PubMed ID: 27555590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruxolitinib attenuates experimental autoimmune encephalomyelitis (EAE) development as animal models of multiple sclerosis (MS).
    Hosseini A; Gharibi T; Mohammadzadeh A; Ebrahimi-Kalan A; Jadidi-Niaragh F; Babaloo Z; Shanehbandi D; Baghbani E; Baradaran B
    Life Sci; 2021 Jul; 276():119395. PubMed ID: 33781828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin Modifies the Development of Lineage-Specific Effector CD4
    Wang J; Niu X; Wu C; Wu D
    Front Immunol; 2018; 9():2267. PubMed ID: 30327657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR26a modulates Th17/T reg balance in the EAE model of multiple sclerosis by targeting IL6.
    Zhang R; Tian A; Wang J; Shen X; Qi G; Tang Y
    Neuromolecular Med; 2015 Mar; 17(1):24-34. PubMed ID: 25362566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
    J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation.
    Gibson SA; Yang W; Yan Z; Liu Y; Rowse AL; Weinmann AS; Qin H; Benveniste EN
    J Immunol; 2017 Jun; 198(11):4244-4254. PubMed ID: 28468969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats.
    Fan C; Long R; You Y; Wang J; Yang X; Huang S; Sheng Y; Peng X; Liu H; Wang Z; Liu K
    Clin Immunol; 2018 Aug; 193():98-109. PubMed ID: 29496642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 Cells and autoimmune encephalomyelitis (EAE/MS).
    Aranami T; Yamamura T
    Allergol Int; 2008 Jun; 57(2):115-20. PubMed ID: 18427164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration.
    Rosenkranz E; Maywald M; Hilgers RD; Brieger A; Clarner T; Kipp M; Plümäkers B; Meyer S; Schwerdtle T; Rink L
    J Nutr Biochem; 2016 Mar; 29():116-23. PubMed ID: 26895672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of RORγt
    Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
    Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity.
    DiToro D; Harbour SN; Bando JK; Benavides G; Witte S; Laufer VA; Moseley C; Singer JR; Frey B; Turner H; Bruning J; Darley-Usmar V; Gao M; Conover C; Hatton RD; Frank S; Colonna M; Weaver CT
    Immunity; 2020 Apr; 52(4):650-667.e10. PubMed ID: 32294406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance.
    Gharibi T; Barpour N; Hosseini A; Mohammadzadeh A; Marofi F; Ebrahimi-Kalan A; Nejati-Koshki K; Abdollahpour-Alitappeh M; Safaei S; Baghbani E; Baradaran B
    Int Immunopharmacol; 2023 Jun; 119():110160. PubMed ID: 37080068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anlotinib attenuates experimental autoimmune encephalomyelitis mice model of multiple sclerosis
    Zhu H; Li G; Yin J; Zhang H; Da Y; Li L
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):594-602. PubMed ID: 35638564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
    Wu D; Wang J; Pae M; Meydani SN
    Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interleukin (IL)-23/T helper (Th)17 Axis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Hiltensperger M; Korn T
    Cold Spring Harb Perspect Med; 2018 Jan; 8(1):. PubMed ID: 29101111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
    Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.